Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody

scientific article published on 01 December 1983

Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00007890-198336060-00005
P953full work available at URLhttp://journals.lww.com/00007890-198336060-00005
P698PubMed publication ID6197792

P2093author name stringE. L. Reinherz
S. F. Schlossman
C. B. Carpenter
T. B. Strom
G. J. Busch
N. L. Tilney
E. L. Milford
R. L. Kirkman
J. L. Araujo
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)620-626
P577publication date1983-12-01
P1433published inTransplantationQ15730500
P1476titleTreatment of acute renal allograft rejection with monoclonal anti-T12 antibody
P478volume36

Reverse relations

cites work (P2860)
Q37390483A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis
Q40770881Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells
Q46622876Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function
Q49043970Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Q39818045Clinical applications of monoclonal antibodies
Q42225955Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital
Q24319426Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
Q33558294Current status of renal transplantation
Q52129450Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications.
Q70386814Experience with cyclosporine and steroids in clinical renal transplantation
Q36257761HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors
Q33573621Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab
Q37138277Immunological evaluation of rheumatoid arthritis patients treated with itolizumab
Q70403714Immunosuppressive agents in renal transplantation
Q40117551Immunosuppressive therapy for renal transplantation
Q34528980In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates
Q36350273In vivo effects of monoclonal antibodies to distinct epitopes of Qa-2 antigens
Q67902658Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with γ/δ rather than α/β aantigen receptors
Q69920215Pediatric renal transplantation
Q35304730Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients
Q33810506Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts
Q70376234Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation
Q38730494Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
Q70014971Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor
Q70235792The Human T-cell Circuit
Q70354867The effect of skin allograft survival of a monoclonal antibody specific for a polymorphic CD3-like cell surface molecule in rhesus monkeys
Q68832714The internal image-like anti-idiotypic response to a CD3-specific monoclonal antibody in primates is dependent on the T cell-binding properties of the injected antibody
Q24336427The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins
Q37333749The potential of biotechnology to improve the quality of life of patients with renal failure
Q37084181The role of OKT3 in clinical transplantation
Q36845422Use of monoclonal antibodies in human transplantation

Search more.